All In Biotech

Drug Trial Radar · NCT06542614

Treatment of Moderate to Severe Plaque Psoriasis

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamic (PD) Profile of TQH3906 in Subjects With Moderate to Severe Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Jan 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 209 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

209

Actual

Start

Aug 27, 2024

Primary completion

Nov 3, 2025

Study completion Dec 6, 2025

Sponsor

Sponsor type
Industry
First posted
Aug 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis, as well as the PK and PD characteristics of multiple doses

Conditions

  • Plaque Psoriasis

Interventions

  • TQH3906 capsulesDrug

    To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis.

  • Placebo of TQH3906 capsulesDrug

    Placebo without drug substance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients achieving Psoriasis Area and Severity Index (PASI) 75 at week 12Time frame: Up to week 12

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Wannan Medical College

    Wuhu, Anhui, China

  • Beijing Tongren Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • The first affiliated hospital of chongqing medical university

    Chongqing, Chongqing Municipality, China

  • Dermatology Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Liuzhou People'S Hospital

    Liuzhou, Guangxi, China

  • Shijiazhuang Hospital of Traditional Chinese Medicine

    Shijiazhuang, Hebei, China

  • The Second Hospital of HeBei Medical University

    Shijiazhuang, Hebei, China

  • The Second Affiliated Hospital Of Xingtai Medical Colledge

    Xingtai, Hebei, China

  • Heilongjiang Provincial Hospital

    Harbin, Heilongjiang, China

  • The Second Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China

  • Nanyang First People'S Hospital

    Nanyang, Henan, China

  • Shiyan Renmin Hospital

    Shiyan, Hubei, China

  • Wuhan First Hospital

    Wuhan, Hubei, China

  • The First People's Hospital of Changde

    Changde, Hunan, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • The First Affiliated Hospital of Baotou Medical College

    Baotou, Inner Mongolia, China

  • Hospital of Dermatology, Chinese Academy of Medical Sciences

    Nanjing, Jiangsu, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

  • Yancheng First People's Hospital

    Yancheng, Jiangsu, China

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China

  • Meihekou Central Hospital

    Meihekou, Jilin, China

  • Genertec Liaoyou Gem Flower Hospital

    Panjin, Liaoning, China

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

  • The first hospital of china medical university

    Shenyang, Liaoning, China

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • Shandong First Medical University Affiliated Dermatology Hospital

    Jinan, Shandong, China

  • Shandong University Qilu Hospital

    Jinan, Shandong, China

  • Qingdao Municipal hospital (group)

    Qingdao, Shandong, China

  • Qingdao Traditional Chinese Medicine Hospital

    Qingdao, Shandong, China

  • Shanghai JiaoTong University of medicine Ruijin Hospital

    Shanghai, Shanghai Municipality, China

  • Shanxi Provincial People's Hospital

    Taiyuan, Shanxi, China

  • Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital

    Tianjin, Tianjin Municipality, China

  • Xinjiang Uygur Autonomous Region People's Hospital

    Ürümqi, Xinjiang, China

  • Affiliated Hangzhou First People'S Hospital,School of Medicine, Westlake University

    Hangzhou, Zhejiang, China

  • The Second Affiliated Hospital Zhejiang University School Of Medicine

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.